Cargando…
Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo/radiotherapy of glioblastoma
Although RNA interference (RNAi) therapy has emerged as a potential tool in cancer therapeutics, the application of RNAi to glioblastoma (GBM) remains a hurdle. Herein, to improve the therapeutic effect of RNAi on GBM, a cancer cell membrane (CCM)-disguised hypoxia-triggered RNAi nanomedicine was de...
Autores principales: | Wang, Zhen, Tang, Xiang-long, Zhao, Meng-jie, Zhang, Yi-ding, Xiao, Yong, Liu, Yu-yang, Qian, Chun-fa, Xie, Yan-dong, Liu, Yong, Zou, Yuan-jie, Yang, Kun, Liu, Hong-yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324258/ https://www.ncbi.nlm.nih.gov/pubmed/37408007 http://dx.doi.org/10.1186/s12951-023-01960-w |
Ejemplares similares
-
Biomimetic ZIF8 Nanosystem With Tumor Hypoxia Relief Ability to Enhance Chemo-Photothermal Synergistic Therapy
por: Zhao, Ziming, et al.
Publicado: (2022) -
Biomimetic nanomedicines for precise atherosclerosis theranostics
por: Tao, Ying, et al.
Publicado: (2023) -
Harnessing RNAi nanomedicine for precision therapy
por: Peer, Dan
Publicado: (2014) -
A Versatile PDA(DOX) Nanoplatform for Chemo-Photothermal Synergistic Therapy against Breast Cancer and Attenuated Doxorubicin-Induced Cardiotoxicity
por: Geng, Siqi, et al.
Publicado: (2023) -
Biomimetic Cucurbitacin B-Polydopamine Nanoparticles for Synergistic Chemo-Photothermal Therapy of Breast Cancer
por: Leng, Junke, et al.
Publicado: (2022)